Objectives : Sesamin, a major lignan in sesame seeds, has been reported to have neuroprotective effects against in vitro ischemia and in vivo MCAo-reperfusion cerebral ischemia model, however, there is no reports in an in vivo global cerebral ischemia model. The purpose of the study was to investigate the neuroprotective effect of sesamin in global cerebral ischemia induced by four-vessel occlusion (4-VO) in rats through inhibition of microglial activation in this model. Methods : The neuroprotective effects were investigated using a 10 min of 4-VO ischemia rat model by measuring intact pyramidal neurons in the CA1 region of the hippocampus using Nissle staining. The antiinflammatory or reducing neurotoxicity effect was investigated using immunohistochemisty, RT-PCR and western blot analysis of inflammatory or neurotoxic mediators. Results : Intraperitoneal injection of sesamin at doses of 0.3, 1.0, 3.0, and 10.0 mg/kg at 0 min and 90 min after ischemia conferred 26.6%, 30.1%, 42.5%, and 30.5% neuroprotection, respectively, compared to the vehicle-treated control group. A 3.0 mg/kg dose of sesamin inhibited microglia activation and consequently, cyclooxygenase-2, inducible nitric oxide, and interleukine-1β expressions at 48 h after reperfusion. Conclusions : Sesamin protects neuronal cell death through inhibition of microglial activation or the production of neurotoxic metabolites and proinflammatory mediators by microglia such as COX-2, iNOS and IL-1β in global cerebral ischemia.
Introduction 1)2)
Sesame, an oilseed from the plant Sesamum indicum, is highly valued as a traditional herb and it may be a potent natural agent with both therapeutic applications and use in preventing human illness 1) . Sesamin, a major lignan in sesame seeds, which comprises approximately 0.5% in sesame seeds 2) , is assumed to play important roles in plant defense and has been frequently used as potent antioxidants 3) . Recently sesamin was reported to have the neuroprotective effect on focal cerebral ischemic damage 4) and intracerebral hemorrhage in rats 5) . This effect is attributed to its antioxidant, antiinflammatory properties 6) and inhibition of microglial activation in murine cell line 5, 7, 8) . However, there is no report of sesamin on global cerebral ischemic injury, which is different from focal cerebral ischemia in that it occurs in serious cardiovascular disorders such as cardiac arrest, cardiogenic shock after myocardial infarction, or reversible severe hypotension 9) . Global cerebral ischemia involves a short very intense insult in which ATP is severely lowered. A histological hallmark of global ischemia is the selective and delayed neuronal loss in the pyramidal neurons and they are most vulnerable cells in loss of blood supply to the brain in the CA1 region of the hippocampus through deleterious biochemical cascades [10] [11] [12] [13] . In the present study, the neuroprotective effect of sesamin was investigated in global ischemia model. 4-VO model was used to induce global cerebral ischemia and reperfusion 14, 15) . We also investigated the effects on microglial activation using immunohistochemistry, RT-PCR and western blot analysis for a histochemical marker of microglia (OX-42), cyclooxygenase-2 (COX-2), inducible nitric oxide (iNOS), and interleukin-1β (IL-1β) following ischemia induction. By using 4-VO rat model, we found that sesamin protected against neuronal cell death and suppressed microglial activation in global cerebral ischemia in rats.
Materials and Methods

Sample preparation
The sesamin used in this study was obtained from Ginseng & Medicinal Crops Division, National Institute of Crop Science (NICS), Rural Development Administration (RDA). The sesamin was dissolved in 5.0% dimethyl sulfoxide (DMSO) and intraperitoneally (i.p.) injected in doses of 0.3, 1.0, 3.0, and 10.0 mg/kg after 0 and 90 min of cerebral ischemia (administration volume, 1.0 ml/kg). A vehicle-treated group was treated with same volume of 5.0% DMSO.
Animal model
All animal procedures were conducted in accordance with the animal welfare guidelines of the Korean National Institute of Health (NIH) and the Korean Academy of Medical Sciences. Male Wistar rats (SLC, Japan) weighing between 160 g and 180 g were housed under controlled-temperature (22 ± 2 ℃), constant-humidity, and 12 h light/dark cycle (lights on 07:00-19:00) conditions, with food and water available ad libitum. Transient global cerebral ischemia was induced by 4-VO according to the method of Pulsinelli and Brierley 14) . The animals were anesthetized with isoflurane (initiated and maintained with 5.0% and 1.5% isoflurane, respectively). After the animals were positioned in stereotaxic ear bars (Kopf Instruments, Tujunga, CA, USA), the vertebral arteries at the first cervical vertebra were coagulated by using the 0.5-mm diameter needle of an electrocoagulator. Both common carotid arteries (CCA) were then isolated and ligated via a ventral, midline cervical incision. On the following day, 10 min of 4-VO ischemia was induced through CCA occlusion by applying aneurysm clips for 10 min. To minimize variability among animals, the following criteria were strictly applied for the 10-min ischemic period and the 20 ± 5 min postischemic coma (loss of righting reflex and bilateral pupil dilation). After 10 min of 4-VO, ligatures in the neck and around the CCAs were removed and the neck wound was closed with surgical clips. Body temperature was monitored and maintained at 37 ± 0.5 ℃ with a heating blanket (Harvard Apparatus, Edenbridge, UK) until 6 h after ischemia. The sham-operated animals underwent the same surgical procedures, with the exception that the CCAs were not occluded.
Histology
At 48 h (for immunohistochemistry of COX-2) or 7 days (for immunohistochemistry of OX-42 and cell counting) after ischemia, the animals were anesthetized and their brains were perfusion-fixed with 4% paraformaldehyde following transcardial wash-out with heparinized 5% sodium nitrite saline. The fixed brains were cut into sections (30-µm thick for cell counting, 40-µm thick for immunohistochemistry) on a HM440E microtome (Carl Zeiss, Germany) and the sections were stained with 0.5% cresyl violet. For each animal, the neuronal cell density was measured by counting viable cells in a total of six frames (1.0 × 1.0 mm2) of the left and right CA1 regions of three coronal sections (× 400; 3.3, 3.5, and 3.7 mm caudal to the Bregma). The neuronal cell density is equivalent to the average number of viable cells in one frame. Cell counting was conducted by three technicians blinded to the experimental conditions.
Immunohistochemistry
Free-floating (40 µm) sections were reacted with a goat polyclonal antibody against COX-2 (diluted 1:1000; Santa Cruz Biotechnology Inc., CA, USA) or a mouse polyclonal antibody against OX-42 (against the CD11b surface antigen, diluted 1:100; Serotec, Oxford, UK) overnight at room temperature. Following incubation, the sections were reacted with anti-goat or anti-mouse antibody (diluted 1:200; Vector Laboratories, CA, USA) for 60 min and then reacted with an avidin-biotin-peroxidase complex kit (diluted 1:50, Elite ABC kit; Vector Laboratories) at room temperature for 60 min. The avidin-biotin complex was visualized with 0.05% 3,3′-diaminobenzidine (DAB, Sigma) and 0.02% H2O2.
Reverse transcription-polymerase chain reaction
At 24 h after ischemia, the tissues were collected and homogenized. The total RNA was extracted using easy-BLUE (iNtRon Biotechnology, Seoul, Korea) and cDNA was synthesized using a ONE-STEP mix (iNtRon Biotechnology). The PCR products were directly synthesized from 2 µg of total RNA isolated from the affected hemispheres using the SuperScript one step RT-PCR system with Platinum Taq (iNtRon Biotechnology) and gene-specific primers, by following the instructions provided by the manufacturer. The reaction mixtures (iNtRon Biotechnology), consisting of 2 µg of total RNA and 5 pmol primers, were incubated at 45℃, denatured at 94℃ for 5 min, and then subjected to 32 amplification cycles (30 s at 94℃, 30 s at 45℃, and 1 min at 70℃). This was followed by a final elongation for 10 min at 70℃. The PCR products were analyzed by agarose gel electrophoresis (1.5%), stained with ethidium bromide, and scanned with a Gel-Doc image analysis system (Bio-Rad, CA, USA). The sequences of iNOS, IL-1β and GAPDH primers were as follows: forward and reverse primers, respectively: 5′-ACA ACG TGG AGA AAA CCC CAG GTG-3′ and 5′-ACA GCT CCG GGC ATC GAA GAC C-3′ for iNOS (566 bp of amplification products); 5′-AGA AGC TGT GGC AGC TAC CT-3′ and 5′-TTG GGA TCC ACA CTC TCC AG-3′ for IL-1β (400 bp of amplification products); 5′-GTG ATG GGT GTG AAC CAC GAG-3′ and 5′-CAG TGA GCT TCC CGT TCA GCT-3′ for GAPDH (295 bp of amplification products).
Western blot analysis
At 48 h after ischemia, the tissues were lysed in triple-detergent lysis buffer (50 mM Tris-HCl, PH 8.0; 150 mM NaCl; 0.1% sodium dodecyl sulfate (SDS); 1% NP-40; 0.02% sodium azide; 0.5% sodium deoxycholate; and 1 mM phenylmethylsulfonylfluoride). A protein sample (30µgforeach) was separated by 8% SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to a Hybond ECL nitrocellulose membrane (Amersham Pharmacia Biotech, Bucking hamshire, UK). The membrane was blocked with 5% skimmed milk and incubated with the primary antibody and horseradish peroxidase (HRP)-conjugated secondary antibody (Santa Cruz Biotechnology Inc., CA, USA). The blots were detected by a West-Zol TM plus western blot detection system (iNtRon Biotechnology, Korea).
Statistical analysis
Data are expressed as the mean ± SEM. Statistical analysis was performed using a one-way ANOVA, followed by Dunnett's posttest to compare all data with control, with the sham-operated or vehicle-treated group. Data was considered to be significant when the P value was less than 0.05.
Results
Sesamin inhibits ischemia-induced neuronal cell death
To investigate whether sesamin has neuroprotective in global cerebral ischemia, we performed 4-VO with rats and measured the neuronal cell density in the CA1 hippocampal region at 7 days after 10 min of ischemia.
In the sham-operated group, the neuronal density in the CA1 region was normal (Fig. 1A) and most of the pyramidal neurons in the CA1 region exhibited an intact morphology and no damaged cells (Fig. 1a) . In the vehicle-treated group, the neuronal density was reduced (Fig. 1B) and the neurons in the CA1 region exhibited a shrunken morphologically and coagulation (Fig. 1b) . The group treated with 3.0 mg/kg sesamin exhibited an increase in neuronal density (Fig. 1C) and, compared with the vehicle-treated group, an increased number of intact pyramidal neurons in the CA1 region (Fig. 1c) .
Ten minutes of ischemia reduced the number of neurons in the CA1 region to 24.3 ± 3.9 cells/mm They reduced the number of damaged pyramidal cells in the CA1 subfield and the 3.0 mg/kg-treated group exhibited a 42.6% neuroprotective effect compared with the sham-operated group (Fig. 2) .
These results clearly indicate that sesamin exhibits a neuroprotective effect in global cerebral ischemia. 
Sesamin inhibits OX-42 upregulation
To study whether sesamin affected microglial activation in global cerebral ischemia, immunohistochemical analysis were used with a histochemical marker of microglia, OX-42. The vehicle-treated control group exhibited a high density of OX-42 positive cells around the CA1 region at 7 days after ischemia (Fig. 3B, b) . Conversely, the sham-operated group exhibited a low density (Fig.  3A, a) . Sesamin reduced the density of OX-42 positive cells compared with vehicle-treated group (Fig. 3C, c) . This suggests that sesamin inhibits OX-42 upregulation and downregulates microglial activation in global cerebral ischemia. 
Sesam in inhibits C O X -2 protein expression
To study whether sesamin reduce neurotoxicity mediated by inflammation in global cerebral ischemia, we observed COX-2 immunoreactivity by immunohistochemistry. A low level of basal COX-2 immunoreactivity occurred in neurons of the pyramidal cell and granule cell layers in the hippocampus of sham-operated group (Fig. 4A, a) . 48 h after 10 min of global cerebral ischemia induced upregulated COX-2 expression in the CA1 to CA3 pyramidal neurons compared with sham-operated group (Fig. 4B, b) . Intraperitoneal injection of sesamin 3.0 mg/kg downregulated COX-2 expression in the CA1 region compared with vehicle-treated group (Fig. 4C, c) . Thus, sesamin reduces the neuronal damage mediated by inflammation in global cerebral ischemia because sesamin inhibits COX-2 expression in the hippocampus. 
Sesamin inhibits iNOS and IL-1β expressions
To study whether sesamin reduces neuronal damage mediated by neurotoxic nitrogen intermediates and proinflammatory cytokines in global cerebral ischemia, we measured iNOS and IL-1β mRNA expressions and immunoreactivity using RT-PCR and western blot analysis. iNOS and IL-1β mRNA expressions were upregulated at 24 h after global ischemia compared with the sham-operated group. The protein expressions were investigated by Western blot analysis at 48 h after ischemia. iNOS and IL-1β expressions were upregulated compared with sham-operated group. On the other hand, Sesamin at 1.0 and 3.0 mg/kg reduced the immunoreactivity of iNOS and IL-1β. 3.0 mg/kg treated group showed more inhibition than 1.0 mg/kg treated group (Fig. 5) . The results indicate that sesamin reduces the neuronal damage mediated by microglia-derived neurotoxic or proinflammatory factors including NO and IL-1β in global cerebral ischemia. 
Discussion
The major findings in this study are that sesamin treatment after the onset of ischemia protected hippocampal CA1 neuronal damage in the transient global ischemia rat model and inhibited the expression of OX-42, COX-2, iNOS and IL-1β. To our knowledge, this is the first report to investigate the neuroprotective effect of sesamin against to global cerebral ischemia in rats.
Intraperitoneal injection of sesamin markedly reduced neuronal cell death in the hippocampal CA1 region in 4-VO rats. This result is consistent with previous in vitro studies which reported that sesamin 50 µM showed 30%-40% of protective effects on OGD induced PC12 cell death 6) . The result suggests that sesamin has neuroprotective effect in global cerebral ischemia-reperfusion injury in rats.
4-VO induces microglial activation in the rat hippocampus 16) . OX-42, a histochemical marker of microglia, was upregulated at 7 days after ischemia, and treatment with sesamin inhibited OX-42 upregulation. Microglial activation is characterized by the release of free radicals and the expression of myeloid markers with morphological transformation 17) , and induces iNOS and COX-2 expression so that produce several potentially neurotoxic substances, including NO and prostaglandins, consequently leading to death of neurons. Microglial activation also produces proinflammatory cytokines, including IL-1β, IL-6, and TNF-α which may exert a direct toxicity on neurons [18] [19] [20] . The result suggests that the neuroprotective effect of sesamin exerts by inhibiting microglial activation in global ischemia.
COX-2, a prostanoid-synthesizing enzyme, is a mitogen-inducible isoform whose reaction products are responsible for many of the cytotoxic effects of inflammation 21, 22) . COX-2 was downregulated by treatment with 3.0 mg/kg sesamin in the CA1 region at 48 h after ischemia. COX-2 expression, induced by microglial activation, is initiated 12 h after ischemia, peaks at 24 h, and remains up to 72 h after global cerebral ischemia in the pyramidal neurons of the CA1 region 23) . While COX-2 over-expressing mice have larger infarcts after experimental stroke 24) , disruption of the COX-2 gene provides protection against ischemic brain injury in rodents 25) . In addition, selective pharmacologic inhibition of COX-2 activity has proven to be a potential therapeutic target against stroke in animal models 21, 22) . The present result suggests that sesamin reduce the neuronal damage through COX-2 inhibition in global ischemia. Following brain ischemia, upregulation of iNOS leads to an overproduction of NO in neurons, endothelial cells, and microglia 26, 27) . The production of NO is attributed to the formation of toxic peroxynitrate, and this causes neuronal damage after brain ischemia 28, 29) . NO involves in the process of neuronal damage following cerebral ischemia 21) . Especially, NO overproduction is induced by microglial activation 18, 19) . Inhibitors of NOS have resulted in significant neuroprotection 30, 31) . In this study, sesamin reduced mRNA expression and immunoreactivity of iNOS. The result was consistent with the previous study that sesamin inhibits NO production, iNOS mRNA and protein expression in LPS-stimulated BV-2 cells 7) . The present data suggests that sesamin inhibit iNOS mRNA and protein expressions in conjunction with the inhibitory effect on microglial activation.
The proinflammatory cytokine IL-1β is known to be the major microglial signal that promotes the cascade of glial cell reactions 32) . IL-1β represents a crucial mediator of neurodegeneration induced by traumatic brain injury 33) . Focal brain ischemia in MCAo-reperfusion rats results in a significant induction of IL-1β mRNA [34] [35] [36] . In the current study, IL-1β mRNA and protein expressions were upregulated at 24 h and at 48 h after 4-VO, respectively, whereas in the sesamin-treatment group, these expressions were inhibited. The result suggests that sesamin reduces the neuronal damage mediated by microglia-derived proinflammatory factor IL-1β in global cerebral ischemia.
Conclusion
In this study for evaluating neuroprotective effects of sesamin against in vivo global cerebral ischemia model, the results were as follows:
1. Sesamin has neuroprotective effect in global cerebral ischemia-reperfusion injury in rats.
2. Sesamin inhibits OX-42 upregulation in global cerebral ischemia.
3. Sesamin reduce the neuronal damage through COX-2 inhibition in global ischemia.
4. Sesamin reduce the immunoreactivity of iNOS and IL-1β that correlated with microglia-derived neurotoxic or proinflammatory factors in global cerebral ischemia.
Together, this study indicates that sesamin protects neuronal cell death through inhibition of microglial activation or the production of neurotoxic metabolites and proinflammatory mediators by microglia such as COX-2, iNOS and IL-1β in global cerebral ischemia. The intake of sesame seed as a rich source of sesamin may provide neuroprotection.
